Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses
Research and development	$ 21,553	$ 9,158
General and administrative	7,256	6,728
Total operating expenses	28,809	15,886
Loss from operations	(28,809)	(15,886)
Other income
Change in fair value of warrant liabilities	297	2,955
Interest income	920	461
Total other income	1,217	3,416
Loss before income taxes	(27,592)	(12,470)
Provision for income taxes	0	0
Net loss and comprehensive net loss	$ (27,592)	$ (12,470)
Loss per share:
Loss per share of common stock, basic (in dollars per share)	$ (3.56)	$ (2.46)
Loss per share of common stock, diluted (in dollars per share)	$ (3.56)	$ (2.46)
Weighted average shares of common stock outstanding:
Weighted average shares of common stock outstanding, basic (in shares)	7,757,128	5,071,101
Weighted average shares of common stock outstanding, diluted (in shares)	7,757,128	5,071,101